Corbus Pharmaceuticals Holdings, Inc.
CRBPDrugs in Pipeline
6
Phase 3 Programs
2
Upcoming Catalysts
2
Next Catalyst
Nov 2026
Market Overview
Stock performance and key metrics
3 upcoming, 1 past
Phase 1 — CRB-913
For obesity. Corbus Pharmaceuticals announced completion of patient dosing in its CANYON-1 Phase 1b trial of CRB-913, a CB1 inverse agonist for obesity treatment. Topline data readout is expected in September 2026.
Phase 1b data showed evidence of reduced neuropsychiatric side effects compared to competing mechanisms
Source2 more catalysts beyond 14 days
Start a 48-hour free trial to see all upcoming catalysts
How CRBP's past catalysts played out
Lenabasum 5 mg
Dermatomyositis
Lenabasum 20 mg
Cystic Fibrosis
JBT-101 (lenabasum)
Cystic Fibrosis
CRB-601 monoclonal antibody
Solid Tumor
CRB-701
Solid Tumor, Adult
JBT-101
Systemic Lupus Erythematosus
| Drug Name | Phase | Indication | Designations | Patent |
|---|---|---|---|---|
Lenabasum 5 mg | Phase 3 | Dermatomyositis | - | - |
Lenabasum 20 mg | Phase 3 | Cystic Fibrosis | - | - |
JBT-101 (lenabasum) | Phase 2 | Cystic Fibrosis | - | - |
CRB-601 monoclonal antibody | Phase 2 | Solid Tumor | - | - |
CRB-701 | Phase 2 | Solid Tumor, Adult | - | - |
JBT-101 | Phase 2 | Systemic Lupus Erythematosus | - | - |
Source: CatalystAlert database (ClinicalTrials.gov, SEC EDGAR)
Full breakdown — the signals behind the verdict
Frequently asked questions
What is in Corbus Pharmaceuticals Holdings, Inc.'s drug pipeline?→
CatalystAlert tracks 6 drug candidates in Corbus Pharmaceuticals Holdings, Inc.'s (CRBP) pipeline across Phase 3, Phase 2. Its lead program is Lenabasum 5 mg (Phase 3). Each drug's phase, indication and upcoming catalysts are listed on this page.
When is Corbus Pharmaceuticals Holdings, Inc.'s next FDA catalyst?→
Corbus Pharmaceuticals Holdings, Inc.'s (CRBP) next tracked catalyst is a Phase 2 expected November 1, 2026. See the catalyst timeline on this page for the full schedule of PDUFA dates, trial readouts and FDA events.
How do I track CRBP biotech catalysts?→
Add CRBP to your CatalystAlert watchlist for alerts ahead of each catalyst, and follow Corbus Pharmaceuticals Holdings, Inc.'s live catalyst calendar, drug pipeline and clinical-trial timeline on this page — sourced from ClinicalTrials.gov, FDA and SEC filings.